JPRN-UMIN000015000已完成未知
Treatment of donor sites using a non cultured autologous cell suspension: A randomized controlled trial - a non cultured autologous cell suspension treated donor sites
Zhu Jia-Yuan0 个研究点目标入组 106 人开始时间: 2014年9月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 106
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 80years-old(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria consisted in the presence of pre-existing local and systemic bacterial infections, pre-existing medical conditions that would interfere with wound healing (diabetes, malignancy, autoimmune disease), renal failure (glomerular filtration rate inferior to 60 ml/min), medications that could interfere with wound healing (corticosteroids), hypersensitivity to Trypsin or Hartmann's solution, a high anesthesiology risk that necessarily postponed surgery.
研究者
相似试验
已完成
不适用
Skin cell and hair follicle cell suspension in combination as a novel surgical approach in vitiligoCTRI/2017/05/008692Postgraduate Institute of Medical Education and Research Chandigarh30
尚未招募
2 期
TO study efficacy of non cultured, non trypsinised epidermal cell transplantation(a type of skin grafting procedure) in stable(non progressive, resitant to medical treatment) vitiligo.CTRI/2020/11/028973Department of Dermatology Venerology and Leprosy
进行中(未招募)
1 期
Adipose tissu derived-stem cells injections from patients with sclerodermia to treat thier refractory digital ulcers.Patients with systemic sclerosis presenting digital ulcer :- located beyond the proximal interphalangeal joint, on finger surface (included periungueal ulcers),- of ischemic origin according to the physician,- not over subcutaneous calcifications or bone relief,- active DU- refractory after 10±2 weeks of standard of care (that is either still active or new occurrence despite standard of care)EUCTR2019-003906-28-FRCHU de Toulouse32
已完成
不适用
Suspension from Patients own skin for correction of depressed area of faceCTRI/2016/11/007500AIIMS New Delhi10
暂停
不适用
Development of histopathological methodology without staining using a spectroscopyEsophageal, gastric, colorectal, hepatic, pancreatic, bile duct, and gallbladder cancerJPRN-UMIN000017045Advanced Cancer Translational Research Institute, Showa University250
